CD15+LOX-1+ PMN-MDSC
frequency is increased in PB of NSCLC patients
To compare the CD15+LOX-1+ PMN-MDSC
frequency in NSCLC patients with that in healthy donors, we detected the
proportion of CD15+LOX-1+ PMN-MDSCs
in PB of the two groups. Detailed information of NSCLC patients were
listed in Table 1. Based on the results of FCM, it was indicated that
CD15+LOX-1+ PMN-MDSC frequency was
significantly up-regulated in the circulation of NSCLC patients
(20.84±1.342 %) compared to healthy individuals (3.215±0.1346 %)
(Figure 1, P <0.0001).